P&S Intelligence

The European Union (EU) point-of-care ultrasound (PoCUS) device market is predicted to generate a revenue of $230.9 million by 2024. Furthermore, the market would advance at a CAGR of 6.1% between 2019 and 2024.

At this growth rate, the needle-free diabetes management market is expected to reach $16,831.5 million by 2025 from $3,830.6 million in 2016.

According to P&S Intelligence, the market generated a revenue of $1,303.9 million in 2020 and it is projected to reach $3,387.4 million by 2030.

According to a P&S Intelligence report, the global aromatherapy market is predicted to attain a revenue of $2,343.0 million by 2025, increasing from $1,152.8 million in 2017, exhibiting a 9.4% CAGR during the forecast period (2018–2025).

Valued at $7,938.7 million in 2015, the global cleanroom consumables market is expected to advance at a CAGR of 4.7% during the forecast period.

The blood screening market had a valuation of $2,402.3 million in 2019 and is predicted to advance at a CAGR of 8.1% from 2020 to 2030.

During the forecast period (2015–2020), the global magnetic resonance imaging (MRI) compatible patient monitoring systems market is projected to witness a 3.1% CAGR.

The transdermal drug delivery systems market is projected to grow from just over $30.0 billion in 2016, to more than $60.0 billion in size by 2023, at a CAGR of 9.8% during 2017–2023 (forecast period).

The market accounted for a $1,468.8-million size in 2019, and it is expected to reach $3,612.9 million by 2030.

Owing to the surging geriatric population, rising prevalence of chronic diseases, and soaring healthcare expenditure in several countries, the demand for portable ultrasound devices is expected to increase in the coming years.